TIRZEPATIDE

TIRZEPATIDE was reported 181068 times

TIRZEPATIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DRUG TITRATION ISSUE 112 0.6120
1 INTERCEPTED PRODUCT SELECTION ERROR 606 0.4654
2 INJECTION SITE COLDNESS 316 0.3726
3 THERAPEUTIC RESPONSE CHANGED 2265 0.3571
4 INTERCEPTED PRODUCT DISPENSING ERROR 589 0.3550
5 ACCIDENTAL UNDERDOSE 4610 0.3200
6 STARVATION KETOACIDOSIS 59 0.2921
7 INJECTION SITE INJURY 1527 0.2751
8 PRODUCT TAMPERING 468 0.2604
9 EXTRA DOSE ADMINISTERED 10288 0.2537
10 GASTRIC HYPOMOTILITY 62 0.2020
11 OBSTRUCTIVE PANCREATITIS 147 0.1922
12 INJECTION SITE HYPERSENSITIVITY 591 0.1888
13 GASTROINTESTINAL HYPOMOTILITY 387 0.1715
14 ERUCTATION 3216 0.1660
15 FOOD CRAVING 794 0.1507
16 HUNGER 2049 0.1469
17 ALLODYNIA 171 0.1463
18 INCORRECT DOSE ADMINISTERED 32155 0.1407
19 INTERCEPTED PRODUCT PRESCRIBING ERROR 185 0.1395
20 IMPAIRED GASTRIC EMPTYING 1873 0.1373
21 SKIN LAXITY 59 0.1347
22 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 56 0.1333
23 INJECTION SITE PARAESTHESIA 171 0.1113
24 LACK OF SATIETY 29 0.1111
25 ACUTE CHOLECYSTITIS NECROTIC 22 0.1095
26 MEDULLARY THYROID CANCER 36 0.1059
27 PRODUCT STORAGE ISSUE 352 0.0928
28 DUODENOGASTRIC REFLUX 25 0.0899
29 INCORRECT PRODUCT FORMULATION ADMINISTERED 71 0.0802
30 OFF LABEL USE OF DEVICE 99 0.0732
31 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1332 0.0726
32 INJECTION SITE HAEMORRHAGE 5540 0.0693
33 INCREASED APPETITE 1271 0.0665
34 INJECTION SITE PUSTULE 24 0.0630
35 INJURY ASSOCIATED WITH DEVICE 1282 0.0629
36 VOMITING PROJECTILE 177 0.0611
37 INJECTION SITE RASH 1866 0.0608
38 INJECTION SITE HYPOAESTHESIA 86 0.0601
39 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 380 0.0585
40 FEEDING DISORDER 1183 0.0583
41 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 69 0.0576
42 DRUG DOSE TITRATION NOT PERFORMED 105 0.0573
43 FOOD AVERSION 97 0.0571
44 ACCIDENTAL OVERDOSE 2090 0.0571
45 POSTMENOPAUSAL HAEMORRHAGE 145 0.0556
46 INJECTION SITE MASS 2028 0.0548
47 INJECTION SITE URTICARIA 1309 0.0533
48 PANCREATIC ENZYMES INCREASED 78 0.0532
49 KETOSIS 56 0.0516
50 GASTROINTESTINAL SOUNDS ABNORMAL 255 0.0514
51 FLUID INTAKE REDUCED 255 0.0509
52 GLYCOSYLATED HAEMOGLOBIN DECREASED 82 0.0509
53 INJECTION SITE VESICLES 301 0.0497
54 INJECTION SITE BRUISING 3941 0.0493
55 INJECTION SITE PRURITUS 3252 0.0485
56 OPTIC ISCHAEMIC NEUROPATHY 187 0.0483
57 INJECTION SITE PAIN 14616 0.0476
58 WRONG PATIENT RECEIVED PRODUCT 138 0.0471
59 BILIARY COLIC 137 0.0470
60 DRUG TITRATION ERROR 120 0.0464
61 THIRST DECREASED 29 0.0462
62 INJECTION SITE LACERATION 29 0.0452
63 INJECTION SITE ERYTHEMA 5616 0.0452
64 INJECTION SITE IRRITATION 571 0.0448
65 INJECTION SITE DISCOMFORT 471 0.0447
66 STARVATION 37 0.0444
67 LIPASE INCREASED 320 0.0417
68 CORTISOL INCREASED 26 0.0416
69 CYCLIC VOMITING SYNDROME 30 0.0410
70 INJECTION SITE INDENTATION 88 0.0406
71 BILIARY OBSTRUCTION 52 0.0401
72 BLOOD INSULIN INCREASED 22 0.0399
73 PAPILLARY THYROID CANCER 68 0.0391
74 OPHTHALMIC MIGRAINE 27 0.0388
75 EARLY SATIETY 75 0.0385
76 PRODUCT AFTER TASTE 36 0.0377
77 COUNTERFEIT PRODUCT ADMINISTERED 48 0.0368
78 THYROID MASS 140 0.0364
79 ILLNESS 3729 0.0362
80 AMYLASE INCREASED 131 0.0355
81 SENSITIVE SKIN 260 0.0352
82 CONSTIPATION 7625 0.0349
83 INJECTION SITE REACTION 2297 0.0333
84 GLYCOSYLATED HAEMOGLOBIN INCREASED 831 0.0329
85 FOOD POISONING 174 0.0325
86 LYMPH NODE PAIN 60 0.0322
87 SKIN SENSITISATION 33 0.0319
88 EUGLYCAEMIC DIABETIC KETOACIDOSIS 130 0.0315
89 GASTRIC PH DECREASED 32 0.0312
90 FLATULENCE 1771 0.0312
91 INJECTION SITE INFLAMMATION 154 0.0309
92 DYSPEPSIA 3016 0.0306
93 PANCREATITIS NECROTISING 68 0.0296
94 DISCOLOURED VOMIT 28 0.0291
95 INTERCEPTED PRODUCT STORAGE ERROR 103 0.0288
96 PANCREATITIS 1451 0.0274
97 INJECTION SITE SCAR 77 0.0270
98 ILEUS 331 0.0266
99 BRAIN FOG 411 0.0262
100 GALLBLADDER ENLARGEMENT 28 0.0260
101 INJECTION SITE SCAB 25 0.0259
102 BLOOD GLUCOSE DECREASED 1245 0.0259
103 BLOOD KETONE BODY INCREASED 20 0.0256
104 INTRUSIVE THOUGHTS 30 0.0255
105 GALLBLADDER INJURY 49 0.0251
106 CHOLELITHIASIS 820 0.0250
107 NAUSEA 19738 0.0249
108 MUSCLE ATROPHY 306 0.0241
109 INJECTION SITE SWELLING 1832 0.0239
110 NOROVIRUS INFECTION 34 0.0235
111 NECK MASS 66 0.0233
112 BINGE EATING 25 0.0232
113 APPENDICITIS 216 0.0231
114 GASTROINTESTINAL DISORDER 2071 0.0231
115 HYPERPHAGIA 92 0.0230
116 GASTROOESOPHAGEAL REFLUX DISEASE 1833 0.0227
117 HYPOPHAGIA 582 0.0227
118 PRODUCT DISPENSING ERROR 490 0.0225
119 CHOLECYSTITIS 264 0.0221
120 INJECTION SITE DRYNESS 20 0.0221
121 PANCREATIC CYST 42 0.0220
122 CHOLECYSTITIS INFECTIVE 61 0.0220
123 BODY MASS INDEX INCREASED 29 0.0215
124 WEIGHT LOSS POOR 108 0.0211
125 COLITIS ISCHAEMIC 142 0.0210
126 CHOLECYSTITIS ACUTE 119 0.0210
127 BREATH ODOUR 51 0.0209
128 DIABETIC RETINOPATHY 71 0.0209
129 BLOOD GLUCOSE ABNORMAL 385 0.0208
130 REGURGITATION 71 0.0207
131 ABDOMINAL PAIN UPPER 4201 0.0204
132 GASTRIC DILATATION 34 0.0204
133 APPENDICITIS PERFORATED 51 0.0200
134 KETOACIDOSIS 150 0.0200
135 GASTROINTESTINAL PAIN 220 0.0200
136 VOMITING 9395 0.0200
137 BILE DUCT STONE 63 0.0198
138 ABDOMINAL RIGIDITY 53 0.0195
139 PANCREATIC DISORDER 96 0.0195
140 DEPRESSED MOOD 1016 0.0192
141 DEPRESSION SUICIDAL 66 0.0190
142 ABDOMINAL DISTENSION 1988 0.0190
143 DYSAESTHESIA 58 0.0189
144 INJECTION SITE CELLULITIS 35 0.0188
145 BOWEL MOVEMENT IRREGULARITY 142 0.0185
146 PRODUCT DOSE OMISSION ISSUE 5418 0.0184
147 INFREQUENT BOWEL MOVEMENTS 45 0.0181
148 INTESTINAL OBSTRUCTION 681 0.0180
149 WEIGHT INCREASED 4035 0.0180
150 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 308 0.0179
151 OBSTRUCTIVE SLEEP APNOEA SYNDROME 26 0.0178
152 DIARRHOEA 11312 0.0175
153 GALLBLADDER DISORDER 312 0.0175
154 ILEUS PARALYTIC 78 0.0175
155 INTERMENSTRUAL BLEEDING 97 0.0173
156 INJECTION SITE INFECTION 57 0.0173
157 DEHYDRATION 2310 0.0173
158 INJECTION SITE WARMTH 356 0.0173
159 GASTROENTERITIS VIRAL 309 0.0171
160 PRODUCT DISPENSING ISSUE 73 0.0170
161 WEIGHT FLUCTUATION 177 0.0169
162 BLOOD GLUCOSE INCREASED 3179 0.0169
163 HYPOGLYCAEMIA 812 0.0167
164 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 283 0.0166
165 ABDOMINAL DISCOMFORT 2745 0.0163
166 RETINOPATHY 61 0.0163
167 INJECTION SITE DISCOLOURATION 203 0.0162
168 PANCREATITIS ACUTE 365 0.0162
169 FAECES HARD 63 0.0162
170 MALNUTRITION 180 0.0161
171 TASTE DISORDER 319 0.0157
172 ALOPECIA 3066 0.0156
173 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 21 0.0155
174 SMALL INTESTINAL OBSTRUCTION 185 0.0150
175 ELECTRIC SHOCK SENSATION 42 0.0150
176 ACUTE ABDOMEN 22 0.0150
177 DECREASED APPETITE 3472 0.0149
178 HEAVY MENSTRUAL BLEEDING 134 0.0149
179 APPETITE DISORDER 98 0.0148
180 VITREOUS DETACHMENT 32 0.0148
181 BLOOD GLUCOSE FLUCTUATION 160 0.0146
182 INJECTION SITE INDURATION 186 0.0143
183 HICCUPS 116 0.0141
184 INTENTIONAL PRODUCT MISUSE 1235 0.0141
185 BLOOD ELECTROLYTES DECREASED 20 0.0141
186 GASTROINTESTINAL MOTILITY DISORDER 75 0.0140
187 INTESTINAL ISCHAEMIA 75 0.0136
188 PANCREATITIS CHRONIC 32 0.0135
189 WRONG PRODUCT ADMINISTERED 90 0.0133
190 VOLVULUS 31 0.0131
191 OESOPHAGEAL SPASM 24 0.0130
192 MOTION SICKNESS 25 0.0130
193 INSURANCE ISSUE 198 0.0129
194 DYSENTERY 24 0.0129
195 THROAT CLEARING 48 0.0128
196 SLEEP DEFICIT 27 0.0128
197 AXILLARY PAIN 19 0.0128
198 LARGE INTESTINAL OBSTRUCTION 28 0.0125
199 GLOMERULAR FILTRATION RATE DECREASED 153 0.0124
200 ABDOMINAL PAIN 2892 0.0124
201 RETCHING 261 0.0122
202 FAECALOMA 67 0.0122
203 GASTROENTERITIS 178 0.0122
204 HYPOGLYCAEMIC UNCONSCIOUSNESS 24 0.0121
205 GASTRITIS 317 0.0120
206 GOITRE 49 0.0120
207 RETINAL ARTERY OCCLUSION 30 0.0119
208 DYSCHEZIA 36 0.0118
209 PRODUCT STORAGE ERROR 1031 0.0118
210 SUSPECTED COUNTERFEIT PRODUCT 46 0.0116
211 PANIC ATTACK 421 0.0115
212 INJECTION RELATED REACTION 19 0.0115
213 OFF LABEL USE 10041 0.0115
214 THIRST 202 0.0113
215 WRONG DOSE 27 0.0112
216 ABNORMAL LOSS OF WEIGHT 75 0.0110
217 PAROSMIA 83 0.0110
218 MATERNAL EXPOSURE DURING PREGNANCY 979 0.0110
219 THERAPY CHANGE 108 0.0110
220 POLYMENORRHOEA 38 0.0109
221 SENSATION OF FOREIGN BODY 92 0.0109
222 FEELING COLD 297 0.0107
223 CHOLANGITIS 66 0.0106
224 OROPHARYNGEAL DISCOMFORT 96 0.0106
225 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1901 0.0105
226 RETINAL TEAR 26 0.0105
227 VISUAL IMPAIRMENT 1298 0.0105
228 DIZZINESS POSTURAL 98 0.0101
229 RENAL PAIN 107 0.0101
230 PERONEAL NERVE PALSY 56 0.0098
231 RED BLOOD CELL COUNT INCREASED 27 0.0098
232 ABDOMINAL TENDERNESS 48 0.0097
233 INSULIN RESISTANCE 20 0.0096
234 SLUGGISHNESS 98 0.0096
235 SKIN WRINKLING 26 0.0096
236 FOOD INTOLERANCE 35 0.0095
237 PRODUCT PRESCRIBING ERROR 227 0.0095
238 DIABETIC KETOACIDOSIS 227 0.0094
239 WEIGHT DECREASED 2596 0.0093
240 HAEMOGLOBIN INCREASED 42 0.0092
241 PHARYNGEAL SWELLING 90 0.0092
242 PAIN OF SKIN 247 0.0092
243 MENOPAUSE 23 0.0089
244 THYROID CANCER 107 0.0089
245 DRUG EFFECT LESS THAN EXPECTED 129 0.0087
246 VITREOUS FLOATERS 85 0.0086
247 MATERNAL EXPOSURE DURING BREAST FEEDING 35 0.0086
248 BLINDNESS TRANSIENT 62 0.0084
249 COLD SWEAT 148 0.0084
250 SKIN ODOUR ABNORMAL 33 0.0084
251 HYPOVOLAEMIA 49 0.0084
252 HAEMATOCRIT INCREASED 19 0.0083
253 HYPERAESTHESIA 68 0.0083
254 PRESYNCOPE 201 0.0083
255 ASTHENOPIA 45 0.0082
256 ANAL INCONTINENCE 73 0.0081
257 PRODUCT COMMUNICATION ISSUE 71 0.0080
258 ELECTROLYTE IMBALANCE 93 0.0080
259 HORMONE LEVEL ABNORMAL 39 0.0080
260 VITAMIN B12 DECREASED 23 0.0080
261 LETHARGY 459 0.0080
262 TRICHORRHEXIS 22 0.0079
263 NEPHROLITHIASIS 359 0.0078
264 SEASONAL ALLERGY 110 0.0078
265 UNDERDOSE 566 0.0077
266 DIVERTICULITIS 214 0.0077
267 SLEEP APNOEA SYNDROME 147 0.0077
268 EPIGASTRIC DISCOMFORT 30 0.0077
269 VITAMIN B12 DEFICIENCY 31 0.0076
270 LYMPHADENOPATHY 270 0.0076
271 SELF-INJURIOUS IDEATION 32 0.0076
272 DRY MOUTH 613 0.0075
273 URINE OUTPUT DECREASED 66 0.0075
274 INJECTION SITE DISCHARGE 40 0.0074
275 MUSCULOSKELETAL CHEST PAIN 115 0.0074
276 HEPATIC STEATOSIS 138 0.0074
277 HYPOACUSIS 318 0.0074
278 OCULAR ICTERUS 32 0.0074
279 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1489 0.0073
280 FATIGUE 5698 0.0073
281 BLINDNESS UNILATERAL 103 0.0073
282 VISION BLURRED 1000 0.0073
283 PARAESTHESIA ORAL 105 0.0073
284 FUNCTIONAL GASTROINTESTINAL DISORDER 25 0.0072
285 PALPITATIONS 844 0.0072
286 DIZZINESS 3593 0.0072
287 FEELING ABNORMAL 1726 0.0072
288 FEELING JITTERY 137 0.0072
289 HEART RATE INCREASED 708 0.0071
290 DECREASED ACTIVITY 77 0.0071
291 MENSTRUAL DISORDER 59 0.0071
292 MENSTRUATION DELAYED 77 0.0071
293 RETINAL DETACHMENT 65 0.0071
294 BLOOD PRESSURE DECREASED 469 0.0071
295 HERNIA 136 0.0070
296 SPINAL STENOSIS 29 0.0070
297 THYROIDITIS 21 0.0070
298 RETINAL VEIN OCCLUSION 20 0.0070
299 INTENTIONAL DOSE OMISSION 198 0.0069
300 GASTROINTESTINAL NECROSIS 20 0.0069
301 ECTOPIC PREGNANCY 21 0.0068
302 NECK PAIN 381 0.0068
303 UPPER-AIRWAY COUGH SYNDROME 56 0.0068
304 SKIN REACTION 95 0.0067
305 FACIAL PAIN 60 0.0067
306 PANIC DISORDER 26 0.0067
307 POOR QUALITY SLEEP 144 0.0067
308 FEELING OF DESPAIR 31 0.0066
309 DIVERTICULUM INTESTINAL 29 0.0066
310 THYROID DISORDER 102 0.0066
311 HYPERTHYROIDISM 95 0.0066
312 FREQUENT BOWEL MOVEMENTS 177 0.0065
313 HYPERSENSITIVITY 1195 0.0064
314 SUNBURN 48 0.0064
315 COLITIS 243 0.0064
316 BLOOD THYROID STIMULATING HORMONE DECREASED 29 0.0064
317 INFUSION SITE HAEMORRHAGE 21 0.0064
318 HEADACHE 3999 0.0064
319 PROTEIN TOTAL DECREASED 24 0.0064
320 AUTOIMMUNE THYROIDITIS 24 0.0063
321 IRRITABLE BOWEL SYNDROME 136 0.0063
322 CARDIAC FLUTTER 41 0.0063
323 RETINAL HAEMORRHAGE 45 0.0063
324 PARANASAL SINUS HYPERSECRETION 24 0.0063
325 DRUG INEFFECTIVE 8287 0.0063
326 MIGRAINE 599 0.0063
327 LYMPHOEDEMA 43 0.0062
328 DUODENITIS 19 0.0062
329 ATTENTION DEFICIT HYPERACTIVITY DISORDER 26 0.0062
330 FLANK PAIN 57 0.0061
331 CONCUSSION 47 0.0061
332 TENSION HEADACHE 26 0.0060
333 ANXIETY 1718 0.0060
334 HAEMATEMESIS 153 0.0060
335 HIATUS HERNIA 78 0.0060
336 BLOOD PHOSPHORUS DECREASED 22 0.0060
337 PERIORBITAL SWELLING 34 0.0060
338 LIP SWELLING 200 0.0060
339 DISCOMFORT 366 0.0060
340 BLOOD POTASSIUM DECREASED 179 0.0059
341 HEART RATE ABNORMAL 33 0.0059
342 CATARACT 352 0.0059
343 ENDOMETRIOSIS 28 0.0059
344 PERIPHERAL COLDNESS 80 0.0058
345 RENAL FUNCTION TEST ABNORMAL 27 0.0058
346 BLOOD MAGNESIUM DECREASED 50 0.0058
347 HYPOAESTHESIA ORAL 87 0.0058
348 FAECES DISCOLOURED 125 0.0058
349 ENERGY INCREASED 34 0.0058
350 PRODUCT ADMINISTRATION INTERRUPTED 45 0.0057
351 DEFAECATION URGENCY 40 0.0057
352 MENISCUS INJURY 35 0.0057
353 GASTROINTESTINAL INFECTION 51 0.0057
354 METABOLIC DISORDER 33 0.0057
355 NEURALGIA 138 0.0057
356 MUSCLE FATIGUE 24 0.0057
357 VAGINAL HAEMORRHAGE 244 0.0056
358 MOOD ALTERED 153 0.0056
359 INFLUENZA 624 0.0056
360 ANAL FISSURE 30 0.0056
361 VIRAL INFECTION 186 0.0056
362 SYNCOPE 559 0.0056
363 ANAPHYLACTIC REACTION 308 0.0056
364 DIARRHOEA HAEMORRHAGIC 52 0.0056
365 SUICIDAL IDEATION 509 0.0056
366 GOUT 99 0.0055
367 BLOOD PRESSURE SYSTOLIC DECREASED 25 0.0055
368 ENTERITIS 35 0.0055
369 BLINDNESS 222 0.0054
370 MYASTHENIA GRAVIS 44 0.0054
371 DRUG INTOLERANCE 526 0.0054
372 URINE ODOUR ABNORMAL 32 0.0054
373 DECREASED INTEREST 32 0.0054
374 URTICARIA 909 0.0054
375 TONGUE DISCOMFORT 23 0.0054
376 BLOOD PRESSURE DIASTOLIC INCREASED 25 0.0054
377 EATING DISORDER 115 0.0054
378 DYSGEUSIA 401 0.0054
379 DEPRESSIVE SYMPTOM 19 0.0054
380 POLLAKIURIA 224 0.0054
381 MACULAR OEDEMA 30 0.0053
382 VERTIGO 326 0.0053
383 OESOPHAGEAL PAIN 21 0.0053
384 MYALGIA 899 0.0053
385 GLUCOSE TOLERANCE IMPAIRED 31 0.0052
386 SKIN MASS 35 0.0052
387 GASTROINTESTINAL INFLAMMATION 41 0.0052
388 ASTHENIA 1967 0.0052
389 MASS 73 0.0052
390 APATHY 76 0.0052
391 DIABETES MELLITUS INADEQUATE CONTROL 92 0.0052
392 BLOOD IRON DECREASED 61 0.0051
393 ABORTION SPONTANEOUS 205 0.0051
394 MALAISE 2237 0.0051
395 DYSPHONIA 298 0.0051
396 CHROMATURIA 115 0.0051
397 DERMATITIS ALLERGIC 64 0.0051
398 BLOOD PRESSURE ABNORMAL 101 0.0051
399 SKIN ABRASION 24 0.0051
400 OCULAR DISCOMFORT 57 0.0051
401 RASH PRURITIC 275 0.0051
402 BLOOD THYROID STIMULATING HORMONE INCREASED 46 0.0050
403 MALABSORPTION 26 0.0050
404 DEPRESSION 1125 0.0049
405 ACCIDENT 59 0.0049
406 MUSCULOSKELETAL DISCOMFORT 85 0.0049
407 HYPERCHLORHYDRIA 29 0.0049
408 HEPATIC PAIN 21 0.0049
409 YELLOW SKIN 23 0.0049
410 DEAFNESS UNILATERAL 27 0.0049
411 CHILLS 573 0.0049
412 ABNORMAL FAECES 40 0.0049
413 INFLUENZA LIKE ILLNESS 401 0.0049
414 JAUNDICE 131 0.0049
415 URINE ABNORMALITY 22 0.0048
416 CHAPPED LIPS 21 0.0048
417 TENDERNESS 50 0.0048
418 NASOPHARYNGITIS 882 0.0048
419 NEOPLASM 55 0.0048
420 NOCTURIA 58 0.0048
421 FEELING OF BODY TEMPERATURE CHANGE 28 0.0048
422 POST-TRAUMATIC STRESS DISORDER 32 0.0048
423 ASPIRATION 52 0.0047
424 PHOTOPSIA 30 0.0047
425 PANCREATIC CARCINOMA 137 0.0047
426 SCRATCH 50 0.0047
427 ANAPHYLACTIC SHOCK 122 0.0047
428 INJECTION SITE NODULE 52 0.0047
429 ORTHOSTATIC HYPOTENSION 82 0.0047
430 SUPRAVENTRICULAR TACHYCARDIA 45 0.0047
431 UTERINE HAEMORRHAGE 20 0.0047
432 INITIAL INSOMNIA 48 0.0047
433 INTENTIONAL UNDERDOSE 34 0.0046
434 AGEUSIA 116 0.0046
435 INFLAMMATORY MARKER INCREASED 23 0.0046
436 VENTRICULAR EXTRASYSTOLES 48 0.0046
437 MUSCLE SPASMS 845 0.0046
438 DRUG INTERACTION 730 0.0046
439 INSOMNIA 1224 0.0046
440 MOBILITY DECREASED 330 0.0046
441 ARTHROPOD BITE 34 0.0046
442 EAR DISCOMFORT 47 0.0046
443 SERUM FERRITIN INCREASED 24 0.0045
444 PHARYNGITIS STREPTOCOCCAL 49 0.0045
445 DRY THROAT 46 0.0045
446 LOW DENSITY LIPOPROTEIN INCREASED 35 0.0045
447 ABDOMINAL PAIN LOWER 114 0.0045
448 UMBILICAL HERNIA 21 0.0045
449 FEAR OF INJECTION 32 0.0045
450 HAEMORRHOIDS 87 0.0045
451 BLEPHAROSPASM 28 0.0044
452 NERVE COMPRESSION 41 0.0044
453 EXPOSURE VIA SKIN CONTACT 115 0.0044
454 KIDNEY INFECTION 87 0.0044
455 RENAL DISORDER 206 0.0044
456 BIPOLAR DISORDER 48 0.0044
457 SNEEZING 99 0.0044
458 AUTOIMMUNE DISORDER 43 0.0044
459 OPTIC NEURITIS 40 0.0044
460 THROAT IRRITATION 197 0.0044
461 BLOOD TRIGLYCERIDES INCREASED 77 0.0044
462 ODYNOPHAGIA 26 0.0044
463 EYE DISORDER 142 0.0043
464 SWELLING OF EYELID 27 0.0043
465 HEPATIC ENZYME INCREASED 293 0.0043
466 INCORRECT DOSAGE ADMINISTERED 21 0.0043
467 MIDDLE INSOMNIA 80 0.0043
468 SKIN SWELLING 37 0.0043
469 HYPERSOMNIA 122 0.0043
470 MUCOUS STOOLS 21 0.0042
471 ALANINE AMINOTRANSFERASE INCREASED 260 0.0042
472 TACHYCARDIA 376 0.0042
473 CARPAL TUNNEL SYNDROME 59 0.0042
474 CEREBRAL DISORDER 31 0.0042
475 DRY EYE 209 0.0042
476 OVERDOSE 901 0.0042
477 MUSCLE STRAIN 36 0.0042
478 APHONIA 58 0.0042
479 HEPATITIS 106 0.0041
480 MICTURITION URGENCY 47 0.0041
481 LIVER INJURY 101 0.0041
482 OBSESSIVE-COMPULSIVE DISORDER 33 0.0041
483 BURNING SENSATION 287 0.0041
484 ANGIOEDEMA 181 0.0041
485 TREMOR 679 0.0041
486 BACK PAIN 945 0.0041
487 HEAD DISCOMFORT 72 0.0041
488 ACIDOSIS 31 0.0041
489 DIABETIC NEUROPATHY 20 0.0040
490 RENAL CYST 32 0.0040
491 OESOPHAGITIS 44 0.0040
492 FOOD ALLERGY 31 0.0040
493 SCIATICA 64 0.0040
494 LIVER FUNCTION TEST INCREASED 86 0.0040
495 SKIN ATROPHY 23 0.0040
496 THERAPY NON-RESPONDER 179 0.0040
497 VITAMIN D DECREASED 34 0.0040
498 POLYP 26 0.0040
499 THERAPEUTIC PRODUCT EFFECT DECREASED 177 0.0039
500 GAIT INABILITY 132 0.0039
501 DERMATITIS CONTACT 45 0.0039
502 LIMB INJURY 107 0.0039
503 ONYCHOCLASIS 27 0.0039
504 THROAT TIGHTNESS 106 0.0039
505 SALIVARY HYPERSECRETION 39 0.0039
506 PANIC REACTION 28 0.0039
507 NERVE INJURY 43 0.0039
508 SKIN LACERATION 42 0.0039
509 METABOLIC ACIDOSIS 123 0.0038
510 BLOOD PRESSURE INCREASED 588 0.0038
511 HYPERVOLAEMIA 19 0.0038
512 MAJOR DEPRESSION 28 0.0038
513 INTESTINAL PERFORATION 43 0.0038
514 MULTIPLE ALLERGIES 30 0.0038
515 HOT FLUSH 288 0.0038
516 BLOOD SODIUM DECREASED 72 0.0038
517 ACUTE KIDNEY INJURY 583 0.0038
518 PRURITUS 1462 0.0038
519 LOSS OF CONSCIOUSNESS 487 0.0038
520 HEAD INJURY 120 0.0038
521 HYPERHIDROSIS 488 0.0038
522 SKIN WARM 22 0.0038
523 BLOOD CHOLESTEROL INCREASED 176 0.0038
524 INFLAMMATION 194 0.0038
525 GROIN PAIN 33 0.0038
526 COVID-19 659 0.0038
527 ANKLE FRACTURE 58 0.0037
528 EYE HAEMORRHAGE 50 0.0037
529 ATRIAL FIBRILLATION 363 0.0037
530 PARAESTHESIA 586 0.0037
531 UTERINE LEIOMYOMA 27 0.0037
532 MACULAR DEGENERATION 44 0.0037
533 RENAL IMPAIRMENT 309 0.0037
534 INJECTION SITE HAEMATOMA 53 0.0036
535 MUSCLE TIGHTNESS 59 0.0036
536 MOUTH SWELLING 21 0.0036
537 BLOOD URINE PRESENT 69 0.0036
538 DYSMENORRHOEA 48 0.0036
539 THERAPEUTIC RESPONSE SHORTENED 120 0.0036
540 COUGH 1013 0.0036
541 LIVER FUNCTION TEST ABNORMAL 105 0.0036
542 GAMMA-GLUTAMYLTRANSFERASE INCREASED 80 0.0036
543 ROAD TRAFFIC ACCIDENT 151 0.0036
544 CONTUSION 346 0.0036
545 TINNITUS 165 0.0036
546 FAECES SOFT 26 0.0036
547 HYPERCALCAEMIA 44 0.0036
548 BRADYKINESIA 21 0.0036
549 MENTAL DISORDER 154 0.0035
550 SLEEP DISORDER 249 0.0035
551 HEPATIC CIRRHOSIS 66 0.0035
552 NIGHT SWEATS 113 0.0035
553 BACK DISORDER 57 0.0035
554 INFUSION SITE SWELLING 22 0.0035
555 PRODUCT DOSE OMISSION IN ERROR 99 0.0035
556 VITAMIN D DEFICIENCY 34 0.0035
557 PAIN 2133 0.0035
558 CHOKING SENSATION 19 0.0034
559 FUNGAL INFECTION 114 0.0034
560 OROPHARYNGEAL PAIN 316 0.0034
561 HIDRADENITIS 31 0.0034
562 RASH 1478 0.0034
563 DYSPHAGIA 321 0.0034
564 EYE PAIN 190 0.0034
565 SWOLLEN TONGUE 105 0.0034
566 LIMB DISCOMFORT 104 0.0034
567 LIGAMENT SPRAIN 33 0.0033
568 FOOT FRACTURE 63 0.0033
569 FEELING HOT 202 0.0033
570 SINUS DISORDER 65 0.0033
571 POST PROCEDURAL COMPLICATION 63 0.0033
572 SKIN FISSURES 64 0.0033
573 BLOOD POTASSIUM INCREASED 53 0.0033
574 PRODUCT USE ISSUE 611 0.0032
575 RASH ERYTHEMATOUS 155 0.0032
576 DIPLOPIA 84 0.0032
577 HAEMATOCHEZIA 178 0.0032
578 FRUSTRATION TOLERANCE DECREASED 26 0.0032
579 PAIN IN JAW 91 0.0032
580 RECTAL HAEMORRHAGE 138 0.0032
581 LACTIC ACIDOSIS 104 0.0032
582 SWELLING 300 0.0032
583 PRODUCT PREPARATION ISSUE 21 0.0032
584 NO ADVERSE EVENT 579 0.0032
585 BLOOD CALCIUM INCREASED 28 0.0032
586 URINARY TRACT INFECTION 543 0.0032
587 VISUAL FIELD DEFECT 23 0.0032
588 PEMPHIGOID 24 0.0032
589 HYPOAESTHESIA 476 0.0032
590 SKIN HAEMORRHAGE 47 0.0032
591 LARGE INTESTINE PERFORATION 22 0.0032
592 ARTHRALGIA 1313 0.0032
593 IRRITABILITY 189 0.0031
594 CYST 39 0.0031
595 SINUSITIS 322 0.0031
596 GINGIVAL PAIN 25 0.0031
597 MENSTRUATION IRREGULAR 83 0.0031
598 HYPOKALAEMIA 143 0.0031
599 BREAST PAIN 33 0.0031
600 CHEST DISCOMFORT 316 0.0031
601 EAR INFECTION 82 0.0031
602 EYE DISCHARGE 32 0.0031
603 BLOOD TESTOSTERONE DECREASED 21 0.0031
604 ASPARTATE AMINOTRANSFERASE INCREASED 163 0.0031
605 FACIAL PARALYSIS 26 0.0030
606 EYE PRURITUS 102 0.0030
607 INFUSION SITE PAIN 39 0.0030
608 SOMNOLENCE 608 0.0030
609 THERAPY CESSATION 155 0.0030
610 ARTERIOSCLEROSIS CORONARY ARTERY 20 0.0030
611 ECZEMA 157 0.0030
612 NEUROPATHY PERIPHERAL 285 0.0030
613 JOINT INJURY 64 0.0030
614 HYPOTENSION 600 0.0030
615 EYE IRRITATION 172 0.0030
616 HERPES ZOSTER 171 0.0030
617 CHEST PAIN 550 0.0030
618 INFUSION SITE ERYTHEMA 25 0.0030
619 HAND FRACTURE 21 0.0030
620 MUSCULAR WEAKNESS 336 0.0030
621 RHINORRHOEA 191 0.0030
622 POST PROCEDURAL INFECTION 24 0.0029
623 MEDICATION ERROR 164 0.0029
624 DYSSTASIA 86 0.0029
625 BRAIN NEOPLASM 27 0.0029
626 EYE SWELLING 109 0.0029
627 FIBROMYALGIA 71 0.0029
628 SKIN BURNING SENSATION 209 0.0029
629 RESTLESS LEGS SYNDROME 53 0.0029
630 NERVOUSNESS 152 0.0029
631 TEMPERATURE INTOLERANCE 30 0.0029
632 PYELONEPHRITIS 25 0.0029
633 ATRIAL FLUTTER 23 0.0029
634 PERIPHERAL SWELLING 444 0.0029
635 EAR PAIN 56 0.0029
636 NEOPLASM MALIGNANT 191 0.0029
637 ARTHRITIS 224 0.0028
638 EYE INFECTION 32 0.0028
639 SWELLING FACE 184 0.0028
640 NASAL CONGESTION 166 0.0028
641 TREATMENT FAILURE 234 0.0028
642 DERMATITIS ATOPIC 148 0.0028
643 MOOD SWINGS 89 0.0028
644 FLUID RETENTION 142 0.0028
645 MUSCLE TWITCHING 64 0.0028
646 BLOOD BILIRUBIN INCREASED 75 0.0028
647 RESPIRATORY SYNCYTIAL VIRUS INFECTION 24 0.0028
648 TENDON RUPTURE 34 0.0028
649 LIP DRY 25 0.0027
650 COLON CANCER 41 0.0027
651 SPINAL DISORDER 26 0.0027
652 HAIR GROWTH ABNORMAL 19 0.0027
653 BLOOD CREATININE INCREASED 179 0.0027
654 PROCEDURAL PAIN 76 0.0027
655 AMENORRHOEA 48 0.0027
656 IMPAIRED QUALITY OF LIFE 39 0.0027
657 PHOTOPHOBIA 51 0.0027
658 BLOOD ALKALINE PHOSPHATASE INCREASED 67 0.0027
659 ERECTILE DYSFUNCTION 69 0.0027
660 POLYURIA 22 0.0027
661 WHITE BLOOD CELL COUNT INCREASED 103 0.0027
662 THINKING ABNORMAL 50 0.0027
663 ABNORMAL DREAMS 74 0.0027
664 PAIN IN EXTREMITY 788 0.0027
665 BACK INJURY 29 0.0027
666 CHOKING 52 0.0027
667 SINUS CONGESTION 36 0.0027
668 BLOOD ALBUMIN DECREASED 21 0.0026
669 OBESITY 42 0.0026
670 DEEP VEIN THROMBOSIS 171 0.0026
671 PERSONALITY CHANGE 24 0.0026
672 ROTATOR CUFF SYNDROME 33 0.0026
673 INTERVERTEBRAL DISC PROTRUSION 56 0.0026
674 ESCHERICHIA INFECTION 21 0.0026
675 TRANSIENT ISCHAEMIC ATTACK 86 0.0025
676 DECREASED IMMUNE RESPONSIVENESS 25 0.0025
677 RASH PAPULAR 57 0.0025
678 TOOTHACHE 46 0.0025
679 TOOTH FRACTURE 28 0.0025
680 CHOLECYSTECTOMY 29 0.0025
681 RASH MACULAR 88 0.0025
682 ANGER 85 0.0025
683 ACCIDENTAL EXPOSURE TO PRODUCT 257 0.0025
684 BRAIN INJURY 25 0.0025
685 MANIA 41 0.0025
686 SENSORY LOSS 20 0.0025
687 SPINAL PAIN 29 0.0025
688 MULTIPLE ORGAN DYSFUNCTION SYNDROME 70 0.0025
689 CARDIAC DISORDER 230 0.0025
690 DRUG-INDUCED LIVER INJURY 77 0.0025
691 PARALYSIS 35 0.0024
692 BLADDER DISORDER 24 0.0024
693 MEMORY IMPAIRMENT 332 0.0024
694 ORAL HERPES 47 0.0024
695 PULMONARY EMBOLISM 228 0.0024
696 PSORIATIC ARTHROPATHY 97 0.0024
697 RIB FRACTURE 49 0.0024
698 OCULAR HYPERAEMIA 113 0.0024
699 SKIN DISCOLOURATION 109 0.0024
700 CANDIDA INFECTION 40 0.0024
701 PHOTOSENSITIVITY REACTION 39 0.0024
702 UPPER LIMB FRACTURE 47 0.0024
703 LOCALISED INFECTION 57 0.0024
704 ORAL CANDIDIASIS 31 0.0024
705 MENTAL IMPAIRMENT 57 0.0023
706 GENERALISED OEDEMA 29 0.0023
707 NIGHTMARE 81 0.0023
708 ORAL PAIN 52 0.0023
709 DISTURBANCE IN ATTENTION 125 0.0023
710 UPPER RESPIRATORY TRACT INFECTION 107 0.0023
711 HYPERKALAEMIA 81 0.0023
712 FALL 768 0.0023
713 SKIN IRRITATION 105 0.0023
714 LOWER LIMB FRACTURE 44 0.0023
715 GAIT DISTURBANCE 437 0.0023
716 ASTHMA 258 0.0023
717 SCAB 26 0.0023
718 TOOTH INFECTION 30 0.0023
719 JOINT DISLOCATION 24 0.0023
720 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 109 0.0023
721 THERAPY INTERRUPTED 161 0.0023
722 LACRIMATION INCREASED 68 0.0022
723 HEPATOMEGALY 22 0.0022
724 BONE PAIN 131 0.0022
725 SECRETION DISCHARGE 28 0.0022
726 GLAUCOMA 43 0.0022
727 RESPIRATORY TRACT INFECTION 58 0.0022
728 SCAR 38 0.0022
729 URINARY RETENTION 74 0.0022
730 LIVER DISORDER 98 0.0022
731 EYE INFLAMMATION 21 0.0022
732 BALANCE DISORDER 190 0.0022
733 ARRHYTHMIA 104 0.0022
734 DISORIENTATION 86 0.0022
735 WRIST FRACTURE 26 0.0022
736 HAIR TEXTURE ABNORMAL 29 0.0022
737 HEART RATE DECREASED 76 0.0022
738 GASTRIC ULCER 41 0.0022
739 PRODUCT DISTRIBUTION ISSUE 20 0.0022
740 NODULE 28 0.0021
741 SKIN INFECTION 24 0.0021
742 SEPSIS 238 0.0021
743 TENDONITIS 33 0.0021
744 HEART RATE IRREGULAR 48 0.0021
745 DEVICE DIFFICULT TO USE 140 0.0021
746 SPEECH DISORDER 110 0.0021
747 CRYING 76 0.0021
748 DRY SKIN 279 0.0021
749 PARANOIA 36 0.0021
750 ORAL DISCOMFORT 29 0.0021
751 EXOSTOSIS 19 0.0021
752 PRODUCTIVE COUGH 99 0.0021
753 INCREASED TENDENCY TO BRUISE 19 0.0021
754 IRON DEFICIENCY ANAEMIA 19 0.0021
755 SPLENOMEGALY 24 0.0020
756 SPINAL FRACTURE 41 0.0020
757 BLOOD CALCIUM DECREASED 23 0.0020
758 HELICOBACTER INFECTION 21 0.0020
759 MUSCULOSKELETAL STIFFNESS 179 0.0020
760 BLOOD UREA INCREASED 34 0.0020
761 SKIN EXFOLIATION 171 0.0020
762 DEVICE DEFECTIVE 35 0.0020
763 ANHEDONIA 53 0.0020
764 DYSURIA 74 0.0020
765 DIABETES MELLITUS 153 0.0020
766 OSTEOARTHRITIS 85 0.0020
767 HYPERGLYCAEMIA 73 0.0020
768 IMMUNE SYSTEM DISORDER 26 0.0020
769 RESTLESSNESS 72 0.0020
770 SURGERY 115 0.0020
771 CEREBROVASCULAR ACCIDENT 332 0.0020
772 DERMATITIS 41 0.0020
773 DEAFNESS 51 0.0019
774 COGNITIVE DISORDER 91 0.0019
775 DYSPNOEA 1102 0.0019
776 COELIAC DISEASE 19 0.0019
777 PRODUCT PRESCRIBING ISSUE 42 0.0019
778 EXPIRED PRODUCT ADMINISTERED 64 0.0019
779 SEIZURE 222 0.0019
780 BREAST CANCER 179 0.0019
781 PETECHIAE 20 0.0019
782 GASTRIC HAEMORRHAGE 22 0.0019
783 CELLULITIS 96 0.0019
784 BRONCHITIS 141 0.0019
785 DENTAL CARIES 21 0.0019
786 BURSITIS 23 0.0019
787 THROMBOSIS 152 0.0019
788 VASCULITIS 22 0.0019
789 HYPOTHYROIDISM 60 0.0019
790 HYPOTHERMIA 19 0.0019
791 SPINAL OPERATION 23 0.0019
792 HEREDITARY ANGIOEDEMA 20 0.0019
793 PRESCRIBED OVERDOSE 36 0.0019
794 WOUND 52 0.0019
795 DYSPNOEA EXERTIONAL 69 0.0018
796 ERYTHEMA 375 0.0018
797 ULCER 29 0.0018
798 URINARY INCONTINENCE 54 0.0018
799 PRODUCT AVAILABILITY ISSUE 41 0.0018
800 RENAL FAILURE 239 0.0018
801 ANOSMIA 26 0.0018
802 HYPERTENSION 378 0.0018
803 BODY HEIGHT DECREASED 19 0.0018
804 SINUS TACHYCARDIA 25 0.0018
805 ARTHROPATHY 97 0.0017
806 MYOCARDIAL INFARCTION 303 0.0017
807 NERVOUS SYSTEM DISORDER 54 0.0017
808 SYSTEMIC LUPUS ERYTHEMATOSUS 61 0.0017
809 SKIN DISORDER 57 0.0017
810 BLOOD TEST ABNORMAL 24 0.0017
811 RHABDOMYOLYSIS 71 0.0017
812 INFECTION 246 0.0017
813 THERAPEUTIC RESPONSE DECREASED 103 0.0017
814 PSYCHOTIC DISORDER 50 0.0017
815 GENERALISED TONIC-CLONIC SEIZURE 28 0.0017
816 GINGIVAL BLEEDING 23 0.0017
817 IMPAIRED WORK ABILITY 36 0.0017
818 C-REACTIVE PROTEIN INCREASED 61 0.0017
819 RESPIRATORY DISORDER 50 0.0017
820 CONJUNCTIVITIS 31 0.0017
821 BACTERIAL INFECTION 31 0.0017
822 MOUTH ULCERATION 35 0.0017
823 PALLOR 45 0.0017
824 INTRAOCULAR PRESSURE INCREASED 21 0.0016
825 PNEUMONIA ASPIRATION 41 0.0016
826 INCORRECT DOSE ADMINISTERED BY DEVICE 43 0.0016
827 CYSTITIS 52 0.0016
828 JOINT SWELLING 197 0.0016
829 EPISTAXIS 122 0.0016
830 ACUTE MYOCARDIAL INFARCTION 48 0.0016
831 HAEMORRHAGE 170 0.0016
832 ISCHAEMIC STROKE 29 0.0016
833 BLOOD PRESSURE FLUCTUATION 39 0.0016
834 SENSORY DISTURBANCE 26 0.0016
835 INCORRECT PRODUCT ADMINISTRATION DURATION 35 0.0016
836 AMNESIA 105 0.0016
837 FLUSHING 164 0.0016
838 PRODUCT PREPARATION ERROR 33 0.0016
839 SKIN LESION 44 0.0016
840 TYPE 2 DIABETES MELLITUS 54 0.0016
841 CLOSTRIDIUM DIFFICILE INFECTION 35 0.0016
842 PULMONARY CONGESTION 21 0.0016
843 DRUG DOSE OMISSION BY DEVICE 124 0.0016
844 PRODUCT ADMINISTRATION ERROR 32 0.0016
845 RESPIRATORY TRACT CONGESTION 25 0.0016
846 CONFUSIONAL STATE 253 0.0016
847 QUALITY OF LIFE DECREASED 21 0.0016
848 GLOSSODYNIA 35 0.0016
849 JOINT STIFFNESS 41 0.0016
850 PYREXIA 535 0.0015
851 PULMONARY MASS 23 0.0015
852 DYSARTHRIA 58 0.0015
853 CORONARY ARTERY OCCLUSION 21 0.0015
854 PRESCRIBED UNDERDOSE 30 0.0015
855 EMOTIONAL DISORDER 46 0.0015
856 APHASIA 45 0.0015
857 FRACTURE 28 0.0015
858 BLISTER 83 0.0015
859 MUSCULOSKELETAL DISORDER 28 0.0015
860 CARDIOVASCULAR DISORDER 37 0.0015
861 DEMENTIA 40 0.0014
862 TOOTH DISORDER 31 0.0014
863 PRODUCT USE IN UNAPPROVED INDICATION 345 0.0014
864 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 65 0.0014
865 PSORIASIS 181 0.0014
866 OSTEOPENIA 21 0.0014
867 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 98 0.0014
868 LYMPHOMA 21 0.0014
869 CHOLESTASIS 26 0.0014
870 HYPONATRAEMIA 76 0.0013
871 OEDEMA 73 0.0013
872 LEUKOCYTOSIS 24 0.0013
873 PELVIC PAIN 24 0.0013
874 CARDIAC ARREST 109 0.0013
875 SEPTIC SHOCK 57 0.0013
876 HYPOKINESIA 19 0.0013
877 HYPOXIA 46 0.0013
878 OXYGEN SATURATION DECREASED 73 0.0013
879 PERICARDIAL EFFUSION 30 0.0013
880 CIRCULATORY COLLAPSE 22 0.0013
881 CHRONIC KIDNEY DISEASE 97 0.0013
882 COLITIS ULCERATIVE 57 0.0013
883 VENTRICULAR TACHYCARDIA 21 0.0013
884 AGITATION 92 0.0013
885 WHEEZING 74 0.0012
886 DRUG RESISTANCE 32 0.0012
887 CEREBRAL INFARCTION 30 0.0012
888 CONTRAINDICATED PRODUCT ADMINISTERED 37 0.0012
889 RENAL INJURY 36 0.0012
890 DRUG LEVEL INCREASED 20 0.0012
891 HEPATIC FUNCTION ABNORMAL 45 0.0012
892 NEEDLE ISSUE 35 0.0012
893 SKIN ULCER 31 0.0012
894 CARDIAC FAILURE 96 0.0012
895 EMOTIONAL DISTRESS 144 0.0012
896 ANGINA PECTORIS 34 0.0012
897 BODY TEMPERATURE INCREASED 24 0.0012
898 SHOCK 27 0.0012
899 HEPATIC FAILURE 35 0.0012
900 PERITONITIS 24 0.0012
901 PROTEINURIA 22 0.0012
902 HIP FRACTURE 37 0.0011
903 MUSCULOSKELETAL PAIN 60 0.0011
904 PRODUCT COMPLAINT 29 0.0011
905 RHEUMATOID ARTHRITIS 129 0.0011
906 MOVEMENT DISORDER 36 0.0011
907 FEAR 30 0.0011
908 INJURY 78 0.0011
909 KNEE ARTHROPLASTY 23 0.0011
910 OEDEMA PERIPHERAL 133 0.0011
911 TRANSAMINASES INCREASED 24 0.0011
912 PNEUMONIA 349 0.0011
913 DELIRIUM 37 0.0011
914 CEREBRAL HAEMORRHAGE 38 0.0011
915 ADVERSE DRUG REACTION 94 0.0010
916 MELAENA 23 0.0010
917 SEROTONIN SYNDROME 20 0.0010
918 MULTIPLE SCLEROSIS 49 0.0010
919 STOMATITIS 62 0.0010
920 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 53 0.0010
921 ACNE 76 0.0010
922 EPILEPSY 30 0.0010
923 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
924 TOOTH LOSS 20 0.0010
925 LUNG DISORDER 47 0.0010
926 THERAPEUTIC RESPONSE UNEXPECTED 43 0.0010
927 IMPAIRED HEALING 31 0.0009
928 CONDITION AGGRAVATED 283 0.0009
929 ASCITES 27 0.0009
930 MENTAL STATUS CHANGES 25 0.0009
931 DEVICE MALFUNCTION 63 0.0009
932 HAEMOPTYSIS 25 0.0009
933 LOWER RESPIRATORY TRACT INFECTION 40 0.0009
934 DEVICE DELIVERY SYSTEM ISSUE 24 0.0009
935 FOETAL EXPOSURE DURING PREGNANCY 71 0.0009
936 ENCEPHALOPATHY 21 0.0009
937 OSTEOPOROSIS 35 0.0009
938 GASTROINTESTINAL HAEMORRHAGE 71 0.0008
939 HAEMATOMA 22 0.0008
940 HEPATIC CANCER 20 0.0008
941 WITHDRAWAL SYNDROME 34 0.0008
942 DEVICE LEAKAGE 35 0.0008
943 DEVICE USE ERROR 28 0.0008
944 RED BLOOD CELL COUNT DECREASED 23 0.0008
945 PULMONARY OEDEMA 36 0.0008
946 GENERAL PHYSICAL HEALTH DETERIORATION 93 0.0008
947 LUNG NEOPLASM MALIGNANT 33 0.0008
948 DISEASE RECURRENCE 38 0.0008
949 DEVICE ISSUE 71 0.0008
950 INTENTIONAL PRODUCT USE ISSUE 69 0.0008
951 DYSKINESIA 32 0.0008
952 CORONARY ARTERY DISEASE 23 0.0008
953 HAEMATURIA 26 0.0008
954 ANAEMIA 143 0.0007
955 BLOOD CREATINE PHOSPHOKINASE INCREASED 21 0.0007
956 STAPHYLOCOCCAL INFECTION 24 0.0007
957 AGGRESSION 36 0.0007
958 ABNORMAL BEHAVIOUR 28 0.0007
959 PLEURAL EFFUSION 42 0.0007
960 UNEVALUABLE EVENT 52 0.0007
961 LABORATORY TEST ABNORMAL 20 0.0007
962 PRODUCT SUBSTITUTION ISSUE 39 0.0007
963 HALLUCINATION 51 0.0007
964 TREATMENT NONCOMPLIANCE 37 0.0007
965 BRADYCARDIA 35 0.0007
966 CARDIAC FAILURE CONGESTIVE 49 0.0006
967 RESPIRATORY FAILURE 42 0.0006
968 INFUSION RELATED REACTION 38 0.0006
969 COMA 27 0.0006
970 EXPOSURE DURING PREGNANCY 35 0.0006
971 WHITE BLOOD CELL COUNT DECREASED 60 0.0006
972 DEATH 475 0.0006
973 DEVICE BREAKAGE 22 0.0005
974 ADVERSE EVENT 49 0.0005
975 DRUG WITHDRAWAL SYNDROME 45 0.0005
976 PLATELET COUNT DECREASED 54 0.0005
977 DEPRESSED LEVEL OF CONSCIOUSNESS 20 0.0005
978 TOXICITY TO VARIOUS AGENTS 85 0.0005
979 SUICIDE ATTEMPT 30 0.0005
980 HAEMOGLOBIN DECREASED 49 0.0005
981 HOSPITALISATION 73 0.0005
982 DEVICE DISLOCATION 19 0.0004
983 THROMBOCYTOPENIA 44 0.0004
984 PROSTATE CANCER 31 0.0004
985 LEUKOPENIA 19 0.0004
986 COMPLETED SUICIDE 30 0.0004
987 PRODUCT QUALITY ISSUE 47 0.0003
988 INTENTIONAL OVERDOSE 22 0.0003
989 NEUTROPENIA 32 0.0002
990 DRUG DEPENDENCE 24 0.0001